Navigation Links
CRESTOR Demonstrates Dramatic CV Risk Reduction in a Large Statin Outcomes Study
Date:11/9/2008

program, designed to address important unanswered questions in statin research. Currently, more than 69,000 patients have been recruited from 55 countries worldwide to participate in the GALAXY Program.

ABOUT CRESTOR (ROSUVASTATIN CALCIUM):

Studies have previously shown that CRESTOR was the most effective statin at lowering LDL-C, had a significant effect on raising HDL-C and slowed the progression of atherosclerosis, an underlying cause of cardiovascular disease.

CRESTOR has now received regulatory approval in over 95 countries. Nearly 15 million patients have been prescribed CRESTOR worldwide. Data from clinical trials and real world use shows that the safety profile for CRESTOR is in line with other marketed statins.

Important Safety Information

CRESTOR is indicated as an adjunct to diet to reduce elevated Total-C, LDL-C, ApoB, non-HDL-C, and TG levels and to increase HDL-C in patients with primary hyperlipidemia and mixed dyslipidemia. CRESTOR is also indicated as an adjunct to diet to slow the progression of atherosclerosis in adult patients as part of a treatment strategy to lower Total-C and LDL-C to target levels. CRESTOR is not approved to prevent cardiovascular morbidity and mortality.

CRESTOR is contraindicated in patients with a known hypersensitivity to any component of this product, in patients with active liver disease, which may include unexplained persistent elevations of hepatic transaminase levels, in women who are pregnant or may become pregnant, and in nursing mothers.

Cases of myopathy and rhabdomyolysis with acute renal failure secondary to myoglobinuria have been reported with HMG-CoA reductase inhibitors, including CRESTOR. These risks can occur at any dose level, but are increased at the highest dose (40 mg).

CRESTOR should be prescribed with caution in patients with predisposing factors for myopathy (eg, age greater than or equal to 65 years, inadequately treated hypothyroidism, rena
'/>"/>

SOURCE AstraZeneca
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Abbott and AstraZeneca Announce Selection of Next-Generation Fenofibrate ABT-335 and CRESTOR(R) Fixed-Dose Combination
2. New Analysis of METEOR Study Demonstrate Effects of AstraZenecas CRESTOR(R) (Rosuvastatin Calcium) on Atherosclerosis in Patients With Two or More Risk Factors for Cardiovascular Disease
3. Phase III Study of Abbotts Investigational TriLipix(TM) in Combination With AstraZenecas CRESTOR(R) Meets Primary Endpoints on Key Lipids
4. Abbotts Phase III Sub-Group Analysis Shows Investigational TriLipix(TM) in Combination with CRESTOR(R) Improves Key Lipids in Patients with Mixed Dyslipidemia and Type 2 Diabetes
5. Cytokine Demonstrates Oral Efficacy of Small-Molecule MIF Inhibitors
6. Lpath Demonstrates Strong Safety Profile of Lead Drug Candidate, Sphingomab(TM), in Non-Human Primates
7. ImmuneRegen BioSciences, Inc. Demonstrates Radilex(TM) Increases Disease-Fighting White Blood Cells
8. New Study Presented at WorldSleep 2007 Demonstrates Ramelteon Has Sustained Efficacy Over Six Months in Adults With Chronic Insomnia
9. Cypher(R) Sirolimus-Eluting Coronary Stent Demonstrates Sustained Clinical Benefits Compared to Bare Metal Stents in Five-Year Randomized Clinical Trial With No Differences in Long-Term Safety
10. Lpath Demonstrates Preclinical Efficacy of Lpathomab(TM) and Initiates Humanization Process
11. R7128 Demonstrates Safety and Potent Antiviral Activity in HCV-Infected Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/4/2015)... 2015 Oramed Pharmaceuticals Inc. (NASDAQ: ... company focused on the development of oral drug delivery ... the upcoming Rodman & Renshaw 17 th Annual ... New York City .  Dr. ... corporate overview on September 9, 2015. ...
(Date:9/4/2015)... Sep. 04, 2015 ... the addition of the "Pharmacovigilance (London, UK ... offering. Understanding PhV today - the ... working in Drug safety. This course ... with pharmacovigilance. New entrants as well as experienced ...
(Date:9/4/2015)... Sep. 04, 2015 ... has announced the addition of the ... 2010-2019" report to their offering. ... containing repeating disaccharide units of Na-glucuronate-N-acetylglucosamine. As ... cartilage matrix, sodium hyaluronate can lubricate the ...
Breaking Medicine Technology:Oramed to Present at the Rodman & Renshaw Global Investment Conference 2Oramed to Present at the Rodman & Renshaw Global Investment Conference 3Pharmacovigilance Course: The Principles and Practice of Global PhV for those Working in Drug Safety (London, UK - December 7-9, 2015) 2Investigation Report on China's Sodium Hyaluronate Market 2015 2
... 1 October is American Pharmacists Month and ... provide outstanding care to their patients every day ... specialty pharmacies across the country. (Logo: ... Pharmacists Month is a time to recognize the ...
... national initiative, the Pediatric Trials Network (PTN), was created ... the National Institutes of Health (NIH).  The PTN will ... Shriver National Institute of Child Health and Human ... medical centers, including Children,s Mercy Hospitals and Clinics.   ...
Cached Medicine Technology:CVS Caremark Recognizes Its 26,000 Pharmacists During October's American Pharmacists Month 2New National Program to Study and Establish Pediatric Dosing 2New National Program to Study and Establish Pediatric Dosing 3
(Date:9/4/2015)... ... September 04, 2015 , ... “Getting away from the ... couples to explore, revitalize and strengthen their ‘couple-ness,’” says Jean Claude Wietzel, general ... Four Seasons Resort Maui, the island’s only Forbes Five Star resort and Travel + ...
(Date:9/4/2015)... ... September 04, 2015 , ... Many consumers are looking for a quick and convenient ... solution. , The patent-pending K Med Cups provide a quick and simple way to brew ... a cold, flu or cough. As a result, they enhance comfort and health. The invention ...
(Date:9/4/2015)... ... September 04, 2015 , ... The USC Eye Institute is proud to announce ... Doximity. Faculty, residents and staff are honored to have contributed to the success ... our ophthalmology residency program. Our faculty places a high priority on our educational programs ...
(Date:9/4/2015)... ... ... access to a doctor can sometimes be a challenge for a variety of reasons. ... affects hospitals’ abilities to provide quality service to those with serious needs, increases insurance ... has recently presented itself, the new telemedicine platform and app, DocChat . ...
(Date:9/4/2015)... New York, NY (PRWEB) , ... September 04, 2015 , ... ... 400 meters qualifying heat, and followed up with victory in the men’s 400 meters ... Caribbean (NACAC) Senior Track and Field Championships in San Jose, Costa Rica in August ...
Breaking Medicine News(10 mins):Health News:Couples Season at Four Seasons Resort Maui Begins This Week With Best Hotel Rates of the Year through November 2Health News:Couples Season at Four Seasons Resort Maui Begins This Week With Best Hotel Rates of the Year through November 3Health News:Redesigned Packaging for Powdered Medicinal Mix Invented by InventHelp® Client (CBA-2637) 2Health News:USC Ophthalmology Residency Program Ranked in Top 10 by Doximity 2Health News:USC Ophthalmology Residency Program Ranked in Top 10 by Doximity 3Health News:Telemedicine Platform DocChat Announces Launch Offering a Way for Patients to Consult Doctors and Receive Prescriptions 24/7 2Health News:Telemedicine Platform DocChat Announces Launch Offering a Way for Patients to Consult Doctors and Receive Prescriptions 24/7 3Health News:Lalonde Gordon’s Recipe Brings Home the Gold 2Health News:Lalonde Gordon’s Recipe Brings Home the Gold 3
... is available in French . Montreal, November ... the marketplace, thanks to a new partnership between Gestion ... a privately owned technology company based in Montreal. ... and its affiliated institutions, and CSI have announced the ...
... Nov. 25, 2009 Physicians at UT Southwestern Medical Center ... breathing in patients with upper spinal-cord injuries or other diseases ... University Hospital St. Paul is only one of only ... country currently equipped to implant the device, called the NeuRx ...
... success for patients with liver lesions, researchers find , ... cetuximab to neoadjuvant chemotherapy can shrink tumors and boost ... with inoperable metastatic liver lesions, new research suggests. ... the body in more than half of patients with ...
... Two experts offer waistline-friendly ways to enjoy festive feasting , ... five-week holiday smorgasbord from Thanksgiving to New Year,s, but are ... off come Jan. 1, help is at hand. , It,s ... make it to 2010 weighing the same as you ...
... ... natural treatments to complement conventional methods. , ... Burnaby, BC (Vocus) November 25, 2009 -- While surgery, chemotherapy ... turn to alternative medicine to help them cope with the side effects of conventional ...
... ... a new market research report is available in its ... (2nd Edition) , http://www.reportlinker.com/p0165301/The-Market-for-Anti-ageing-Foods-(2nd-Edition ).html , ... a fast pace with growth outstripping that of conventional ...
Cached Medicine News:Health News:Univalor and Cognitive Sensing Inc. to commercialize 4 University of Montreal discoveries 2Health News:New device implanted by surgeons help paralyzed patients breathe easier 2Health News:Cetuximab Helps Treat Colorectal Cancer 2Health News:Holiday Eating Without the Guilt -- or the Pounds 2Health News:Holiday Eating Without the Guilt -- or the Pounds 3Health News:Holistic and Western Medicine Combined Can Fight Cancer 2Health News:Reportlinker Adds The Market for Anti-ageing Foods (2nd Edition) 2Health News:Reportlinker Adds The Market for Anti-ageing Foods (2nd Edition) 3Health News:Reportlinker Adds The Market for Anti-ageing Foods (2nd Edition) 4Health News:Reportlinker Adds The Market for Anti-ageing Foods (2nd Edition) 5Health News:Reportlinker Adds The Market for Anti-ageing Foods (2nd Edition) 6Health News:Reportlinker Adds The Market for Anti-ageing Foods (2nd Edition) 7
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: